ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685827 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685827; 2) Community: the network communities that were significantly associated with the response to NSC 685827; 3) Molecule: the relationships between components within communities and NSC 685827; 4) MDR: the compounds that were significantly associated with the NSC 685827.

NSC Compound Enrichment Correlation
NSC 681645 Camptothecin Derivative 0.0112341530780142 0.0078400223
NSC 682866 Ethanone, 1-[7-(4-chlorophenyl)-5,6-dihydro-9-methyl- 7H-benzo[h]thiazolo[2,3-b]quinazolin-10-yl]- 0.0112341530780142 0.35075806
NSC 683326 Null 0.0112341530780142 0.42371533
NSC 683558 Camptothecin Derivative 0.0112341530780142 -0.017686609
NSC 625350 Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (9,10-dihydro-9,10-dioxo-2-anthracenyl)methyl ester (R*,R*) 0.0114254401179199 -0.40750161
NSC 691422 Acetonitrile, [11-(3,4-dimethoxyphenyl)-8,10-diphenyl- 8H,11H-pyrazolo[4',3':5,6]pyrano[3,2-e][1,2,4]-triazolo [1,5-c]pyrimidin-2-yl]- 0.01142544011792 -0.23007259
NSC 752879 3-(3-chloro-5-methoxyphenyl)-N-(2-(4-methylpiperazin-1-yl)ethyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.01142544011792 -0.3680939
NSC 212446 Null 0.0114553853234976 0.3207935
NSC 302289 BOHLMANN K2631 0.0114553853234976 0.19601478
NSC 3053 Actinomycin D 0.0114553853234976 0.29221577
Total:136  Current:54    [First] [Prev] [Next] [Last]